Form 8-K - Current report:
SEC Accession No. 0001193125-25-028110
Filing Date
2025-02-18
Accepted
2025-02-18 06:44:52
Documents
13
Period of Report
2025-02-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d901841d8k.htm   iXBRL 8-K 43889
  Complete submission text file 0001193125-25-028110.txt   164435

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rcus-20250215.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20250215_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20250215_pre.xml EX-101.PRE 10806
15 EXTRACTED XBRL INSTANCE DOCUMENT d901841d8k_htm.xml XML 3499
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 25632660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)